Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? (2012)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM
- Unidade: FM
- DOI: 10.1186/ar4055
- Subjects: NECROSE; BIOMARCADORES; INFLAMAÇÃO (PARÂMETROS); ESPONDILITE ANQUILOSANTE; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Arthritis research & therapy
- ISSN: 1478-6354
- Volume/Número/Paginação/Ano: v. 14, n. 5, p. (online), 2012
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SAAD, Carla G. S. et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?. Arthritis research & therapy, v. 14, n. 5, p. (online), 2012Tradução . . Disponível em: http://arthritis-research.com/content/pdf/ar4055.pdf. Acesso em: 30 abr. 2024. -
APA
Saad, C. G. S., Ribeiro, A. C. M., Moraes, J. C. B., Takayama, L., Goncalves, C. R., Rodrigues, M. B., et al. (2012). Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis research & therapy, 14( 5), (online). doi:10.1186/ar4055 -
NLM
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 abr. 30 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf -
Vancouver
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 abr. 30 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf - Effectiveness of medial-wedge insole treatment for valgus knee osteoarthritis
- Is anti-TNF switching in refractory Still's disease safe and effective?
- Metabolic syndrome in rheumatological diseases
- High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis
- Coronary arterial calcification: classical cardiovascular risk factors versus lupus-related factors
- High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis
- Juvenile onset Takayasu arteritis: poor prognosis and refractory disease
- Juvenile onset systemic lupus erythematosus thyroid dysfunction: A subgroup with mild disease?
- Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials
- Juvenile-onset Takayasu arteritis: peculiar vascular involvement and more refractory disease
Informações sobre o DOI: 10.1186/ar4055 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
